MANUFACTURE, LICENSE AND DISTRIBUTION AGREEMENT BY AND BETWEEN PERRIGO COMPANY OF SOUTH CAROLINA, INC. AND SCOLR PHARMA, INC. October 20, 2005Manufacture, License and Distribution Agreement • March 23rd, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS LICENSE AGREEMENT (this “Agreement”), is entered into as of October 20, 2005, by and between Perrigo Company of South Carolina, Inc., a Michigan corporation, with offices at 515 Eastern Avenue, Allegan, Michigan 49010 (“Perrigo”), and SCOLR Pharma, Inc., a Delaware corporation, with offices at 3625 132nd Avenue SE, Suite 300, Bellevue, Washington 98006 (together with its Affiliates, collectively, “SCOLR Pharma”).
DEVELOPMENT AND LICENSE AGREEMENT by and between WYETH, acting through its WYETH CONSUMER HEALTHCARE DIVISION and SCOLR PHARMA, INC. December 21, 2005Development and License Agreement • March 23rd, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances • New York
This Development and License Agreement (the “Agreement”) is entered into this 21st day of December 2005 (the “Execution Date”), by and between Wyeth, together with its Affiliates (as defined below), acting through its Wyeth Consumer Healthcare Division, a corporation organized and existing under the laws of the State of Delaware and having a place of business at Five Giralda Farms, Madison, New Jersey 07940 U.S.A. (collectively, “Wyeth”) and SCOLR Pharma, Inc., a corporation organized and existing under the laws of the State of Delaware and having a place of business at 3625 132nd Avenue SE, Suite 300, Bellevue, Washington 98006 U.S.A. (“SCOLR”). Wyeth and SCOLR may each be referred to herein individually as a “Party” and collectively as the “Parties.”
FIRST AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • March 23rd, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances
This First Amendment to Office Lease Agreement (this “Amendment”) is dated for reference purposes as of the 15th day of September, 2005, by and between NEWPORT CORPORATE CENTER LLC, a Washington limited liability company (“Landlord”), and SCOLR Pharma, INC., a Delaware corporation (“Tenant”).
